SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 14 Sep 2018)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 07 Sep 2018)
>> Read More

3-(1-OXO-4-((4-((3-OXOMORPHOLINO)METHYL)BENZYL)OXY)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND ISOTOPOLOGUES THEREOF (Fri, 31 Aug 2018)
>> Read More

METHODS FOR TREATING HEMATOLOGICAL CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR FOR RESPONSIVENESS TO TREATMENT COMPOUNDS (Fri, 24 Aug 2018)
>> Read More

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF (Fri, 10 Aug 2018)
>> Read More

METHODS FOR MEASURING SMALL MOLECULE AFFINITY TO CEREBLON (Fri, 10 Aug 2018)
>> Read More

METHODS FOR TREATING HEMATOLOGICAL CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR FOR RESPONSIVENESS TO TREATMENT COMPOUNDS (Fri, 10 Aug 2018)
>> Read More

METHODS FOR MEASURING SMALL MOLECULE AFFINITY TO CEREBLON (Fri, 10 Aug 2018)
>> Read More

METHODS OF SYNTHESIS OF (1R,2R,5R)-5-AMINO-2-METHYLCYCLOHEXANOL HYDROCHLORIDE AND INTERMEDIATES USEFUL THEREIN (Fri, 03 Aug 2018)
>> Read More

3-(1-OXO-4-((4-((3-OXOMORPHOLINO) METHYL)BENZYL)OXY)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND ISOTOPOLOGUES THEREOF (Fri, 03 Aug 2018)
>> Read More

ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER (Thu, 02 Aug 2018)
>> Read More

SOLID FORMS COMPRISING 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF (Fri, 20 Jul 2018)
>> Read More

SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Fri, 20 Jul 2018)
>> Read More

ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 06 Jul 2018)
>> Read More

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 (Fri, 29 Jun 2018)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 15 Jun 2018)
>> Read More

5-SUBSTITUTED ISOINDOLINE COMPOUNDS (Thu, 31 May 2018)
>> Read More

BROMODOMAIN INHIBITORS (Fri, 18 May 2018)
>> Read More

METHODS FOR TREATING DISEASES USING ISOINDOLINE COMPOUNDS (Thu, 17 May 2018)
>> Read More

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS (Fri, 11 May 2018)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 04 May 2018)
>> Read More

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY (Fri, 04 May 2018)
>> Read More

6-, 7-, OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Fri, 04 May 2018)
>> Read More

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY (Fri, 04 May 2018)
>> Read More

BROMODOMAIN INHIBITOR (Fri, 27 Apr 2018)
>> Read More

PROCESSES FOR THE PREPARATION OF (S)-1-(3-ETHOXY-4METHOXYPHENYL)-2-METHANESULFONYLETHYLAMINE (Thu, 26 Apr 2018)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 20 Apr 2018)
>> Read More

SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Thu, 19 Apr 2018)
>> Read More

DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR (Fri, 06 Apr 2018)
>> Read More

COMPOUNDS AND METHODS FOR TREATING LUPUS (Fri, 06 Apr 2018)
>> Read More

Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor (Fri, 06 Apr 2018)
>> Read More

Solid Forms of an Epidermal Growth Factor Kinase Inhibitor (Fri, 06 Apr 2018)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 16 Mar 2018)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Fri, 16 Mar 2018)
>> Read More

CXCR3 RECEPTOR AGONISTS (Fri, 09 Mar 2018)
>> Read More

BROMODOMAIN INHIBITORS (Thu, 08 Mar 2018)
>> Read More

METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE (Fri, 02 Mar 2018)
>> Read More

MORPHIC FORMS OF MARIZOMIB AND USES THEREOF (Fri, 23 Feb 2018)
>> Read More

Histone demethylase inhibitors (Fri, 16 Feb 2018)
>> Read More

BROMODOMAIN INHIBITOR (Fri, 16 Feb 2018)
>> Read More

METHODS OF TREATMENT OF MALIGNANCIES (Fri, 16 Feb 2018)
>> Read More

PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS (Fri, 16 Feb 2018)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 16 Feb 2018)
>> Read More

Compositions comprising an inhibitor of lysine specific demethylase-1 (Fri, 16 Feb 2018)
>> Read More

TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS (Fri, 16 Feb 2018)
>> Read More

ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Fri, 09 Feb 2018)
>> Read More

METHODS OF TREATMENT OF MYELODYSPLASTIC SYNDROME (Fri, 09 Feb 2018)
>> Read More

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 (Fri, 02 Feb 2018)
>> Read More

Bromodomain Inhibitor (Sat, 27 Jan 2018)
>> Read More

GLP-1 receptor modulators (Fri, 26 Jan 2018)
>> Read More

Antiproliferative compounds and methods of use thereof (Fri, 26 Jan 2018)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 26 Jan 2018)
>> Read More

BROMODOMAIN INHIBITOR (Sat, 20 Jan 2018)
>> Read More

SOLID DISPERSIONS AND COCRYSTALS COMPRISING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE COMPOSITIONS AND METHODS OF USE THEREOF (Fri, 19 Jan 2018)
>> Read More

SOLID DISPERSIONS AND SOLID FORMS COMPRISING 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE, METHOD OF PREPARATION AND USE THEREOF (Fri, 19 Jan 2018)
>> Read More

SOLID FORMS COMPRISING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF (Fri, 05 Jan 2018)
>> Read More

5-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Fri, 29 Dec 2017)
>> Read More

BIOMOLECULE CONJUGATES (Fri, 22 Dec 2017)
>> Read More

4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS (Fri, 22 Dec 2017)
>> Read More

4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same (Wed, 20 Dec 2017)
>> Read More

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE (Fri, 15 Dec 2017)
>> Read More

5-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Sat, 09 Dec 2017)
>> Read More

Animal and human anti-trypanosomonal and anti-leishmania agents (Fri, 08 Dec 2017)
>> Read More

Animal and human anti-malarial agents (Fri, 08 Dec 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 08 Dec 2017)
>> Read More

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE (Fri, 08 Dec 2017)
>> Read More

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 (Fri, 08 Dec 2017)
>> Read More

ANIMAL AND HUMAN ANTI-MALARIAL AGENTS (Fri, 08 Dec 2017)
>> Read More

ANIMAL AND HUMAN ANTI-TRYPANOSOMONAL AND ANTI-LEISHMANIA AGENTS (Fri, 08 Dec 2017)
>> Read More

Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses (Fri, 01 Dec 2017)
>> Read More

Histone demethylase inhibitors (Fri, 17 Nov 2017)
>> Read More

NOVEL GLP-1 RECEPTOR MODULATORS (Fri, 03 Nov 2017)
>> Read More

Histone demethylase inhibitors (Fri, 03 Nov 2017)
>> Read More

5-SUBSTITUTED QUINAZOLINONE DERIVATIVES AS ANTI-CANCER AGENTS (Thu, 02 Nov 2017)
>> Read More

THERAPEUTIC COMPOUNDS (Fri, 27 Oct 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 27 Oct 2017)
>> Read More

Histone demethylase inhibitors (Fri, 20 Oct 2017)
>> Read More

METHODS OF USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE (Fri, 06 Oct 2017)
>> Read More

Solid forms of an epidermal growth factor receptor kinase inhibitor (Fri, 06 Oct 2017)
>> Read More

Histone demethylase inhibitors (Fri, 29 Sep 2017)
>> Read More

Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases (Fri, 22 Sep 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 22 Sep 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 22 Sep 2017)
>> Read More

SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 22 Sep 2017)
>> Read More

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (Fri, 15 Sep 2017)
>> Read More

Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same (Fri, 15 Sep 2017)
>> Read More

Purification of Romidepsin (Sat, 26 Aug 2017)
>> Read More

METHODS FOR TREATING SOLID TUMORS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES (Fri, 25 Aug 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 25 Aug 2017)
>> Read More

Histone demethylase inhibitors (Fri, 25 Aug 2017)
>> Read More

Novel GLP-1 receptor modulators (Sat, 19 Aug 2017)
>> Read More

Forms and compositions of an ERK inhibitor (Fri, 11 Aug 2017)
>> Read More

ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Thu, 10 Aug 2017)
>> Read More

ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Thu, 10 Aug 2017)
>> Read More

Ligand-Directed Covalent Modification of Protein (Fri, 04 Aug 2017)
>> Read More

Salts of an epidermal growth factor receptor kinase inhibitor (Fri, 04 Aug 2017)
>> Read More

GLP-1 receptor modulators (Fri, 04 Aug 2017)
>> Read More

INTERMEDIATE FOR THE SYNTHESIS OF 3-(5-AMINO-2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL)PIPERIDINE-2,6-DIONE (Thu, 03 Aug 2017)
>> Read More

MK2 inhibitors and uses thereof (Wed, 02 Aug 2017)
>> Read More

ERK inhibitors and uses thereof (Fri, 28 Jul 2017)
>> Read More

Antiproliferative compounds, and their pharmaceutical compositions and uses (Fri, 14 Jul 2017)
>> Read More

Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (Fri, 14 Jul 2017)
>> Read More

SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 14 Jul 2017)
>> Read More

METHODS FOR TREATING CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES (Fri, 14 Jul 2017)
>> Read More

SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL) METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 14 Jul 2017)
>> Read More

ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES (Fri, 14 Jul 2017)
>> Read More

FORMULATIONS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE (Fri, 14 Jul 2017)
>> Read More

METHODS FOR TREATING CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES (Fri, 14 Jul 2017)
>> Read More

Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (Fri, 14 Jul 2017)
>> Read More

METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE (Fri, 14 Jul 2017)
>> Read More

Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies (Fri, 14 Jul 2017)
>> Read More

Antiproliferative compounds, and their pharmaceutical compositions and uses (Fri, 14 Jul 2017)
>> Read More

Solid forms of 2-(4-chlorophenyl)-N-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses (Fri, 14 Jul 2017)
>> Read More

COMPOSITIONS AND METHODS FOR INDUCING CONFORMATIONAL CHANGES IN CEREBLON AND OTHER E3 UBIQUITIN LIGASES (Fri, 07 Jul 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 07 Jul 2017)
>> Read More

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY (Fri, 30 Jun 2017)
>> Read More

Histone demethylase inhibitors (Fri, 30 Jun 2017)
>> Read More

BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY (Fri, 30 Jun 2017)
>> Read More

Histone demethylase inhibitors (Fri, 23 Jun 2017)
>> Read More

Protein Kinase Conjugates and Inhibitors (Fri, 23 Jun 2017)
>> Read More

3-(4-((4-(MORPHOLINOMETHYL-BENZYL)OXY)-1 -OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (Fri, 23 Jun 2017)
>> Read More

SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND COMBINATION THERAPY THEREWITH (Fri, 16 Jun 2017)
>> Read More

Bromodomain inhibitors (Fri, 09 Jun 2017)
>> Read More

CYCLING THERAPY USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE (Fri, 09 Jun 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 09 Jun 2017)
>> Read More

Histone demethylase inhibitors (Fri, 09 Jun 2017)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 09 Jun 2017)
>> Read More

METHODS OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA USING 3-(4-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE (Fri, 09 Jun 2017)
>> Read More

CYCLING THERAPY USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE (Fri, 09 Jun 2017)
>> Read More

TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA AND OF NON-HODGKIN'S LYMPHOME USING LENALIDOMIDE (Fri, 09 Jun 2017)
>> Read More

Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione (Fri, 09 Jun 2017)
>> Read More

APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY (Fri, 26 May 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 19 May 2017)
>> Read More

ERK inhibitors and uses thereof (Fri, 19 May 2017)
>> Read More

HCV PROTEASE INHIBITORS AND USES THEREOF (Fri, 19 May 2017)
>> Read More

CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF (Fri, 19 May 2017)
>> Read More

Compositions comprising an inhibitor of lysine specific demethylase-1 (Fri, 12 May 2017)
>> Read More

Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine (Fri, 12 May 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 12 May 2017)
>> Read More

6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same (Fri, 12 May 2017)
>> Read More

COMPOSITIONS COMPRISING AN INHIBITOR OF LYSINE SPECIFIC DEMETHYLASE-1 (Fri, 12 May 2017)
>> Read More

Compositions comprising an inhibitor of lysine specific demethylase-1 (Fri, 12 May 2017)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Fri, 05 May 2017)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Fri, 05 May 2017)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Fri, 05 May 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 28 Apr 2017)
>> Read More

Histone demethylase inhibitors (Fri, 28 Apr 2017)
>> Read More

2,4-disubstituted pyrimidines useful as kinase inhibitors (Fri, 14 Apr 2017)
>> Read More

METHODS FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA AND THE USE OF BIOMARKERS AS A PREDICTOR OF RESPONSIVENESS TO DRUGS (Fri, 31 Mar 2017)
>> Read More

Isoindoline compounds and methods of their use (Fri, 31 Mar 2017)
>> Read More

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES WITH PDE4 MODULATORS (Fri, 31 Mar 2017)
>> Read More

METHODS FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA AND THE USE OF BIOMARKERS AS A PREDICTOR OF RESPONSIVENESS TO DRUGS (Fri, 31 Mar 2017)
>> Read More

Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs (Fri, 31 Mar 2017)
>> Read More

METHODS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES USING CEREBLON AS A PREDICTOR (Fri, 31 Mar 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 24 Mar 2017)
>> Read More

BESYLATE SALT OF A BTK INHIBITOR (Thu, 23 Mar 2017)
>> Read More

Histone demethylase inhibitors (Fri, 10 Mar 2017)
>> Read More

Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl) piperidine-2,6-dione (Fri, 03 Mar 2017)
>> Read More

Bromodomain inhibitors (Fri, 24 Feb 2017)
>> Read More

Heteroaryl compounds and uses thereof (Fri, 24 Feb 2017)
>> Read More

METHODS FOR TREATING SOLID TUMORS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES (Fri, 17 Feb 2017)
>> Read More

METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES (Fri, 10 Feb 2017)
>> Read More

METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES (Fri, 10 Feb 2017)
>> Read More

Heterocyclic compounds and uses thereof (Fri, 03 Feb 2017)
>> Read More

METHODS OF SYNTHESIS OF (1R,2R,5R)-5-AMINO-2-METHYLCYCLOHEXANOL HYDROCHLORIDE AND INTERMEDIATES USEFUL THEREIN (Fri, 03 Feb 2017)
>> Read More

Novel GLP-1 receptor modulators (Fri, 03 Feb 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 03 Feb 2017)
>> Read More

Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein (Fri, 03 Feb 2017)
>> Read More

Antiproliferative compounds and methods of use thereof (Fri, 03 Feb 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 03 Feb 2017)
>> Read More

Histone demethylase inhibitors (Fri, 03 Feb 2017)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 20 Jan 2017)
>> Read More

Antiproliferative compounds and methods of use thereof (Fri, 13 Jan 2017)
>> Read More

Romidepsin formulations and uses thereof (Fri, 13 Jan 2017)
>> Read More

Romidepsin formulations and uses thereof (Fri, 06 Jan 2017)
>> Read More

ROMIDEPSIN FORMULATIONS AND USES THEREOF (Fri, 23 Dec 2016)
>> Read More

ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Thu, 22 Dec 2016)
>> Read More

METHODS FOR DETERMINING DRUG EFFICACY FOR TREATMENT OF CANCER USING RATIOS OF CEREBLON ASSOCIATED PROTEINS (Fri, 09 Dec 2016)
>> Read More

METHODS FOR DETERMINING DRUG EFFICACY FOR TREATMENT OF CANCER USING RATIOS OF CEREBLON ASSOCIATED PROTEINS (Fri, 09 Dec 2016)
>> Read More

4'-O-SUBSTITUTED ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Thu, 08 Dec 2016)
>> Read More

Histone demethylase inhibitors (Fri, 02 Dec 2016)
>> Read More

Histone demethylase inhibitors (Fri, 02 Dec 2016)
>> Read More

5-substituted isoindoline compounds (Fri, 02 Dec 2016)
>> Read More

HETEROARYL COMPOUNDS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO (Fri, 25 Nov 2016)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 25 Nov 2016)
>> Read More

Histone demethylase inhibitors (Fri, 18 Nov 2016)
>> Read More

Mutant-selective EGFR inhibitors and uses thereof (Fri, 18 Nov 2016)
>> Read More

Heteroaryl compounds and uses thereof (Fri, 18 Nov 2016)
>> Read More

Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor (Fri, 04 Nov 2016)
>> Read More

LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN (Fri, 04 Nov 2016)
>> Read More

ROMIDEPSIN FORMULATIONS AND USES THEREOF (Thu, 03 Nov 2016)
>> Read More

Use of PDE4 inhibitors and combinations thereof for the treatment of cystic fibrosis (Wed, 02 Nov 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 28 Oct 2016)
>> Read More

GLP-1 receptor stabilizers and modulators (Fri, 28 Oct 2016)
>> Read More

METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS (Fri, 28 Oct 2016)
>> Read More

BROMODOMAIN INHIBITOR (Fri, 28 Oct 2016)
>> Read More

BROMODOMAIN INHIBITOR (Fri, 28 Oct 2016)
>> Read More

Bromodomain inhibitor (Fri, 28 Oct 2016)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 21 Oct 2016)
>> Read More

Substituted 2,4-diaminopyrimidines as kinase inhibitors (Fri, 21 Oct 2016)
>> Read More

BROMODOMAIN INHIBITOR (Fri, 21 Oct 2016)
>> Read More

Bromodomain inhibitor (Fri, 21 Oct 2016)
>> Read More

Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof (Fri, 14 Oct 2016)
>> Read More

Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds (Fri, 14 Oct 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 30 Sep 2016)
>> Read More

METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE (Fri, 09 Sep 2016)
>> Read More

Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof (Fri, 02 Sep 2016)
>> Read More

5-SUBSTITUTED ISOINDOLINE COMPOUNDS (Thu, 01 Sep 2016)
>> Read More

ALGORITHM FOR DESIGNING IRREVERSIBLE INHIBITORS (Fri, 26 Aug 2016)
>> Read More

GLP-1 receptor modulators (Fri, 12 Aug 2016)
>> Read More

Heterocyclic compounds and uses thereof (Fri, 12 Aug 2016)
>> Read More

Heteroaryl compounds and uses thereof (Fri, 05 Aug 2016)
>> Read More

ISOINDOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USE THEREOF FOR PREPARATION OF MEDICAMENTS (Mon, 01 Aug 2016)
>> Read More

ISOINDOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USE THEREOF FOR PREPARATION OF A MEDICAMENT (Mon, 01 Aug 2016)
>> Read More

HETEROCYCLIC COMPOUNDS AND USES THEREOF (Mon, 01 Aug 2016)
>> Read More

Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses (Fri, 29 Jul 2016)
>> Read More

GLP-1 receptor modulators (Fri, 29 Jul 2016)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Thu, 21 Jul 2016)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Thu, 21 Jul 2016)
>> Read More

4,6-disubstituted pyrimidines as kinase inhibitors (Wed, 20 Jul 2016)
>> Read More

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE (Thu, 14 Jul 2016)
>> Read More

Histone demethylase inhibitors (Fri, 08 Jul 2016)
>> Read More

Histone demethylase inhibitors (Fri, 08 Jul 2016)
>> Read More

Histone demethylase inhibitors (Fri, 08 Jul 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 01 Jul 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 01 Jul 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 24 Jun 2016)
>> Read More

SOLID FORMS COMPRISING (1E, 4E)-2-AMINO-N,N-DIPROPYL-8-(4-(PYRROLIDINE-1-CARBONYL)PHENYL)-3H-BENZO[B]AZEPINE-4-CARBOXAMIDE, COMPOSITIONS THEREOF, AND USES THEREOF (Fri, 24 Jun 2016)
>> Read More

ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME (Fri, 24 Jun 2016)
>> Read More

Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo(b)azepine-4-carboxamide, compositions thereof, and uses thereof (Fri, 24 Jun 2016)
>> Read More

GLP-1 RECEPTOR MODULATORS (Fri, 17 Jun 2016)
>> Read More

GLP-1 receptor modulators (Fri, 17 Jun 2016)
>> Read More

GLP-1 RECEPTOR MODULATORS (Fri, 17 Jun 2016)
>> Read More

Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same (Fri, 10 Jun 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 10 Jun 2016)
>> Read More

Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same (Fri, 10 Jun 2016)
>> Read More

BIOMOLECULE CONJUGATES (Fri, 10 Jun 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 10 Jun 2016)
>> Read More

4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS (Fri, 10 Jun 2016)
>> Read More

4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors (Fri, 10 Jun 2016)
>> Read More

SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR (Fri, 10 Jun 2016)
>> Read More

SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR (Fri, 10 Jun 2016)
>> Read More

Biomolecule conjugates (Fri, 10 Jun 2016)
>> Read More

BIOMOLECULE CONJUGATES (Fri, 10 Jun 2016)
>> Read More

4,6-SUBSTITUTED-PYRAZOLO[1,5-A]PYRAZINES AS JANUS KINASE INHIBITORS (Fri, 10 Jun 2016)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 03 Jun 2016)
>> Read More

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione (Fri, 03 Jun 2016)
>> Read More

METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE (Thu, 02 Jun 2016)
>> Read More

Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same (Fri, 20 May 2016)
>> Read More

Heteroaryl compounds and uses thereof (Fri, 13 May 2016)
>> Read More

Controlled release oral dosage forms of poorly soluble drugs and uses thereof (Fri, 13 May 2016)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 13 May 2016)
>> Read More

Histone demethylase inhibitors (Fri, 06 May 2016)
>> Read More

Bromodomain inhibitors (Fri, 06 May 2016)
>> Read More

Bromodomain inhibitors (Fri, 29 Apr 2016)
>> Read More

Histone demethylase inhibitors (Fri, 29 Apr 2016)
>> Read More

Isoindoline compounds and methods of their use (Fri, 29 Apr 2016)
>> Read More

Histone demethylase inhibitors (Fri, 22 Apr 2016)
>> Read More

Histone demethylase inhibitors (Fri, 22 Apr 2016)
>> Read More

Inhibitors of lysine specific demethylase-1 (Fri, 22 Apr 2016)
>> Read More

METHODS FOR TREATING SOLID TUMORS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES (Fri, 22 Apr 2016)
>> Read More

USE OF BIOMARKERS FOR PREDICTING CLINICAL SENSITIVITY TO CANCER TREATMENT (Fri, 15 Apr 2016)
>> Read More

SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND -1-OXOISOINDOLINES AND METHOD OF REDUCING TNFALPHA LEVELS (Fri, 08 Apr 2016)
>> Read More

ERK inhibitors and uses thereof (Fri, 25 Mar 2016)
>> Read More

Histone demethylase inhibitors (Fri, 25 Mar 2016)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 25 Mar 2016)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 25 Mar 2016)
>> Read More

MK2 INHIBITORS AND USES THEREOF (Fri, 25 Mar 2016)
>> Read More

HISTONE DEMETHYLASE INHIBITORS (Fri, 25 Mar 2016)
>> Read More

Histone demethylase inhibitors (Fri, 25 Mar 2016)
>> Read More

MK2 inhibitors and uses thereof (Fri, 25 Mar 2016)
>> Read More

MK2 inhibitors and uses thereof (Fri, 18 Mar 2016)
>> Read More

Romidepsin formulations and uses thereof (Fri, 11 Mar 2016)
>> Read More

Romidepsin formulations and uses thereof (Fri, 11 Mar 2016)
>> Read More

Histone demethylase inhibitors (Fri, 11 Mar 2016)
>> Read More

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 (Fri, 11 Mar 2016)
>> Read More

SYNTHESIS OF 3-(5-AMINO-2-METHYL-4-OXOQUINAZOLIN-3(4H)-YL) PIPERIDINE-2,6-DIONE (Thu, 10 Mar 2016)
>> Read More

Histone demethylase inhibitors (Fri, 04 Mar 2016)
>> Read More

Romidepsin solid forms and uses thereof (Fri, 04 Mar 2016)
>> Read More

Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof (Fri, 19 Feb 2016)
>> Read More

METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST (Fri, 19 Feb 2016)
>> Read More

Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A RAF INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A TOR INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND AN EGFR INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

DOSAGE TITRATION OF APREMILAST FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A BCL-2 PATHWAY MODULATOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

FORMS AND COMPOSITIONS OF AN ERK INHIBITOR (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A PI3K INHIBITOR OR DUAL PI3K/TOR INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

METHODS OF TREATMENT USING AN ERK INHIBITOR (Fri, 19 Feb 2016)
>> Read More

HETEROARYL COMPOUNDS AND USES THEREOF (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A DOT1L INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

COMBINATIONS OF AN ERK INHIBITOR AND A CDK4/6 INHIBITOR AND RELATED METHODS (Fri, 19 Feb 2016)
>> Read More

ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER (Thu, 18 Feb 2016)
>> Read More

Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof (Fri, 12 Feb 2016)
>> Read More

GLP-1 receptor modulators (Fri, 12 Feb 2016)
>> Read More

Histone demethylase inhibitors (Fri, 12 Feb 2016)
>> Read More

RESISTANCE BIOMARKERS FOR HDAC INHIBITORS (Fri, 05 Feb 2016)
>> Read More

Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine (Fri, 05 Feb 2016)
>> Read More

Site Search